Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Effectiveness of a Low Intensity Cranial PEMF Device in Improving Chemotherapy Induced Peripheral Neuropathy Symptoms

NCT07061769 is registered in ClinicalTrials.gov with FluxWear, INC as lead sponsor.

NCT NCT07061769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07061769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Effectiveness of a Low Intensity Cranial PEMF Device in Improving Chemotherapy Induced Peripheral Neuropathy Symptoms
Lead sponsor
FluxWear, INC
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
June 23, 2025
Completion date
July 15, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced neuropathic pain, chemotherapy induced pain neuropathy, chemotherapy induced peripheral neuropathy, chemotherapy induced peripheral neuropathy (cipn)